Validating imunohistochemical staining for KIT (CD117)

被引：35

作者：

Hornick, JL

Fletcher, CDM

机构：

[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

来源：

AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2003年 / 119卷 / 03期

关键词：

D O I：

10.1309/EJ3RY45QCYPUKQG4

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：325 / 327

页数：3

共 14 条

[1] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].

Demetri, GD ;

von Mehren, M ;

Blanke, CD ;

Van den Abbeele, AD ;

Eisenberg, B ;

Roberts, PJ ;

Heinrich, MC ;

Tuveson, DA ;

Singer, S ;

Janicek, M ;

Fletcher, JA ;

Silverman, SG ;

Silberman, SL ;

Capdeville, R ;

Kiese, B ;

Peng, B ;

Dimitrijevic, S ;

Druker, BJ ;

Corless, C ;

Fletcher, CDM ;

Joensuu, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480

[2] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].

Druker, BJ ;

Tamura, S ;

Buchdunger, E ;

Ohno, S ;

Segal, GM ;

Fanning, S ;

Zimmermann, J ;

Lydon, NB .

NATURE MEDICINE, 1996, 2 (05) :561-566

[3] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[4] Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].

Fletcher, CDM ;

Berman, JJ ;

Corless, C ;

Gorstein, F ;

Lasota, J ;

Longley, BJ ;

Miettinen, M ;

O'Leary, TJ ;

Remotti, H ;

Rubin, BP ;

Shmookler, B ;

Sobin, LH ;

Weiss, SW .

HUMAN PATHOLOGY, 2002, 33 (05) :459-465

[5] Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor [J].

Heinrich, MC ;

Griffith, DJ ;

Druker, BJ ;

Wait, CL ;

Ott, KA ;

Zigler, AJ .

BLOOD, 2000, 96 (03) :925-932

[6] Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations [J].

Heinrich, MC ;

Rubin, BP ;

Longley, BJ ;

Fletcher, JA .

HUMAN PATHOLOGY, 2002, 33 (05) :484-495

[7] Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [J].

Hirota, S ;

Isozaki, K ;

Moriyama, Y ;

Hashimoto, K ;

Nishida, T ;

Ishiguro, S ;

Kawano, K ;

Hanada, M ;

Kurata, A ;

Takeda, M ;

Tunio, GM ;

Matsuzawa, Y ;

Kanakura, Y ;

Shinomura, Y ;

Kitamura, Y .

SCIENCE, 1998, 279 (5350) :577-580

[8]

Hornick JL, 2002, AM J CLIN PATHOL, V117, P188

[9] c-Kit expression in desmoid fibromatosis - Comparative immunohistochemical evaluation of two commercial antibodies [J].

Lucas, DR ;

Al-Abbadi, M ;

Tabaczka, P ;

Hamre, MR ;

Weaver, DW ;

Mott, MJ .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (03) :339-345

[10] Response of extraabdominal desmoid tumors to therapy with imatinib mesylate [J].

Mace, J ;

Biermann, JS ;

Sondak, V ;

McGinn, C ;

Hayes, C ;

Thomas, D ;

Baker, L .

CANCER, 2002, 95 (11) :2373-2379

← 1 2 →